ICU Medical, Inc.
ICUI
$0.23 (0.16%)
1D
1W
3M
1Y
5Y
ALL
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
GlobeNewsWire • 17 days ago • ICUI
ICU Medical to Participate at the Piper Sandler 37th Annual Healthcare Conference
Zacks Investment Research • 30 days ago • ICUI
ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates
Seeking Alpha • 30 days ago • ICUI
ICU Medical, Inc. (ICUI) Q3 2025 Earnings Call Transcript
GlobeNewsWire • 30 days ago • ICUI
ICU Medical Announces Third Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance
GlobeNewsWire • about 2 months ago • ICUI
ICU Medical Announces Time of Third Quarter 2025 Earnings Conference Call
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.